Indivior Pharmaceuticals, Inc. INDV Interest Income
Interest Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's interest income?
- Indivior Pharmaceuticals, Inc. (INDV) reported interest income of $3M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's interest income changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's interest income decreased by 25.0% year-over-year, from $4M to $3M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's interest income?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's interest income has grown at a 5.0% compound annual growth rate (CAGR), from $19M to $22M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.